Could a scalp gel save your hair during chemo? early trial begins
Symptom relief
Recruiting now
This early-phase trial tests a topical phenylephrine gel applied daily to the scalp for three weeks. Researchers want to see how much of the drug enters the bloodstream and whether it is safe. The study involves 24 healthy women aged 18-55, not cancer patients, so it is a first s…
Phase: EARLY_PHASE1 • Sponsor: Applied Biology, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC